Empagliflozin and Heart Failure
Circulation
.
2019 Jun 18;139(25):2831-2834.
doi: 10.1161/CIRCULATIONAHA.119.040921.
Epub 2019 Jun 17.
Authors
Subodh Verma
1
,
Carolyn S P Lam
2
3
4
,
Mikhail Kosiborod
4
5
6
Affiliations
1
Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Canada (S.V.).
2
Duke-National University Singapore Medical School, National Heart Centre Singapore, National University Heart Centre (C.S.P.L.).
3
Department of Cardiology, University Medical Center Groningen, the Netherlands (C.S.P.L.).
4
The George Institute for Global Health, Sydney, Australia (C.S.P.L., M.K.).
5
Saint Luke's Mid America Heart Institute, Kansas City, MO (M.K.).
6
University of Missouri-Kansas City (M.K.).
PMID:
31206327
DOI:
10.1161/CIRCULATIONAHA.119.040921
No abstract available
Keywords:
Editorials; empagliflozin; heart failure.
Publication types
Editorial
Comment
MeSH terms
Benzhydryl Compounds
Glucosides*
Heart Failure*
Hospitalization
Humans
Substances
Benzhydryl Compounds
Glucosides
empagliflozin